Health Discovery Corporation Announces Addition to Its Board of ......
Health Discovery Corporation announced today that William F. Quirk, Jr. has been named to the Company's board of directors. Mr. Quirk is the first outside director to join HDC's board succeeding Dr. David Cooper, the Company's former president and chief medical officer who recently resigned his positions to pursue other interests. Quirk is a private investor who purchased a significant equity stake in the company in its successful private placement in July 2005.
"Attracting an outside director of Bill Quirk's caliber is a very significant step in strengthening our company and our board," said HDC's Chairman & CEO, Stephen D. Barnhill, M.D., "As our company matures from a research and development firm into a true operating enterprise, the addition of other well qualified independent directors will further solidify HDC's leadership and Bill has agreed to lead this effort. His broad experience, leadership abilities and commitment to our goals will serve the company well as it approaches commercial viability."
"I'm quite pleased to join the HDC's board of directors," said Quirk. "When I first invested in the company, I felt that HDC was uniquely positioned for success, and I feel that even more so today based on HDC's progress since that time. I look forward to working closely with Dr. Barnhill as we build an independent board of non-management directors whose experience and vision will allow the company to reach its full potential."
William F. Quirk, Jr. is a private investor and a native of Philadelphia. Prior to his retirement in 1996, he held a variety of senior executive positions in finance and management including: Fidelity Management & Research in the mutual fund industry; the investment banking firm Peterson, Diehl, Quirk & Company; leveraged buyout firm Kelso & Company; and auto parts supplier Inline Brake Manufacturing. Quirk earned his B.S. from the U.S. Naval Academy and an MBA from the Harvard Business School.
Savannah-based Health Discovery Corporation (OTCBB:HDVY) is uniquely positioned in the field of pattern recognition technology. Through the application of its patent protected technology, Health Discovery is a biology-oriented biomarker and pathway discovery company providing all aspects of First-Phase Biomarker Discovery(sm). The Company's pattern recognition technology also holds significant application potential in other sizable commercial markets such as diagnostics, Internet search and spam, homeland security, financial futures, and other areas where analysis of complex data is required.
This news release contains "forward-looking statements" within the meaning of Section 27a of the Securities Acts of 1933 and Section 21E of the Securities Exchange Act of 1934. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove correct.
This is cache, read story here